• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对扩展携带者筛查面板上的 176 个基因进行严重程度评估和分类。

Evaluation and classification of severity for 176 genes on an expanded carrier screening panel.

机构信息

Division of Medical Affairs, Myriad Women's Health, South San Francisco, CA, USA.

Department of Pediatric Genetics, Boston University School of Medicine, Boston, MA, USA.

出版信息

Prenat Diagn. 2020 Sep;40(10):1246-1257. doi: 10.1002/pd.5762. Epub 2020 Jun 16.

DOI:10.1002/pd.5762
PMID:32474937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7540025/
Abstract

BACKGROUND

Disease severity is important when considering genes for inclusion on reproductive expanded carrier screening (ECS) panels. We applied a validated and previously published algorithm that classifies diseases into four severity categories (mild, moderate, severe, and profound) to 176 genes screened by ECS. Disease traits defining severity categories in the algorithm were then mapped to four severity-related ECS panel design criteria cited by the American College of Obstetricians and Gynecologists (ACOG).

METHODS

Eight genetic counselors (GCs) and four medical geneticists (MDs) applied the severity algorithm to subsets of 176 genes. MDs and GCs then determined by group consensus how each of these disease traits mapped to ACOG severity criteria, enabling determination of the number of ACOG severity criteria met by each gene.

RESULTS

Upon consensus GC and MD application of the severity algorithm, 68 (39%) genes were classified as profound, 71 (40%) as severe, 36 (20%) as moderate, and one (1%) as mild. After mapping of disease traits to ACOG severity criteria, 170 out of 176 genes (96.6%) were found to meet at least one of the four criteria, 129 genes (73.3%) met at least two, 73 genes (41.5%) met at least three, and 17 genes (9.7%) met all four.

CONCLUSION

This study classified the severity of a large set of Mendelian genes by collaborative clinical expert application of a trait-based algorithm. Further, it operationalized difficult to interpret ACOG severity criteria via mapping of disease traits, thereby promoting consistency of ACOG criteria interpretation.

摘要

背景

在考虑将基因纳入生殖扩展携带者筛查 (ECS) 面板时,疾病严重程度很重要。我们应用了一种经过验证和先前发表的算法,将疾病分为四个严重程度类别(轻度、中度、重度和重度),对 ECS 筛选的 176 个基因进行分类。然后将算法中定义严重程度类别的疾病特征映射到美国妇产科医师学会 (ACOG) 引用的四个与严重程度相关的 ECS 面板设计标准。

方法

八名遗传咨询师 (GC) 和四名医学遗传学家 (MD) 将严重程度算法应用于 176 个基因的子集。然后,MD 和 GC 通过小组共识确定这些疾病特征中的每一个如何映射到 ACOG 严重程度标准,从而确定每个基因符合 ACOG 严重程度标准的数量。

结果

在共识 GC 和 MD 应用严重程度算法后,68 个(39%)基因被归类为重度,71 个(40%)为重度,36 个(20%)为中度,1 个(1%)为轻度。在将疾病特征映射到 ACOG 严重程度标准后,发现 176 个基因中的 170 个(96.6%)至少符合四个标准之一,129 个基因(73.3%)至少符合两个,73 个基因(41.5%)至少符合三个,17 个基因(9.7%)符合所有四个标准。

结论

本研究通过协作临床专家应用基于特征的算法对一组大型孟德尔基因进行了严重程度分类。此外,它通过疾病特征映射使难以解释的 ACOG 严重程度标准具有操作性,从而促进了 ACOG 标准解释的一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/3f0f265f023a/PD-40-1246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/ce7ae3493a81/PD-40-1246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/cb328a772cb3/PD-40-1246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/87a18e2d7eb3/PD-40-1246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/3f0f265f023a/PD-40-1246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/ce7ae3493a81/PD-40-1246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/cb328a772cb3/PD-40-1246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/87a18e2d7eb3/PD-40-1246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b88f/7540025/3f0f265f023a/PD-40-1246-g004.jpg

相似文献

1
Evaluation and classification of severity for 176 genes on an expanded carrier screening panel.对扩展携带者筛查面板上的 176 个基因进行严重程度评估和分类。
Prenat Diagn. 2020 Sep;40(10):1246-1257. doi: 10.1002/pd.5762. Epub 2020 Jun 16.
2
A data-driven evaluation of the size and content of expanded carrier screening panels.基于数据的扩展携带者筛查面板大小和内容的评估。
Genet Med. 2019 Sep;21(9):1931-1939. doi: 10.1038/s41436-019-0466-5. Epub 2019 Feb 28.
3
Prenatal genetic carrier screening in the genomic age.基因组时代的产前遗传携带者筛查。
Semin Perinatol. 2018 Aug;42(5):303-306. doi: 10.1053/j.semperi.2018.07.019. Epub 2018 Jul 26.
4
Expanded Carrier Screening.扩展型携带者筛查。
Obstet Gynecol Clin North Am. 2018 Mar;45(1):103-112. doi: 10.1016/j.ogc.2017.10.005.
5
Comparing ethnicity-based and expanded carrier screening methods at a single fertility center reveals significant differences in carrier rates and carrier couple rates.比较单一生育中心基于种族和扩展携带者筛查方法,揭示了携带者率和携带者夫妇率的显著差异。
Genet Med. 2019 Jun;21(6):1400-1406. doi: 10.1038/s41436-018-0331-y. Epub 2018 Oct 16.
6
Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.在构建临床实用的扩展携带者筛查面板中寻求中间立场。
Obstet Gynecol. 2017 Aug;130(2):279-284. doi: 10.1097/AOG.0000000000002139.
7
Reproductive genetic carrier screening in pregnancy: improving health outcomes and expanding access.孕期生殖遗传携带者筛查:改善健康结局并扩大可及性
J Perinat Med. 2024 Jun 27;52(7):688-695. doi: 10.1515/jpm-2024-0059. Print 2024 Sep 25.
8
A guidelines-consistent carrier screening panel that supports equity across diverse populations.一份符合指南的携带者筛查面板,为不同人群提供公平支持。
Genet Med. 2022 Jan;24(1):201-213. doi: 10.1016/j.gim.2021.09.009. Epub 2021 Nov 30.
9
Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.扩展性携带者筛查:当夫妇中一方被确定为携带者时,经济负担和决策因素
J Assist Reprod Genet. 2021 Apr;38(4):957-963. doi: 10.1007/s10815-021-02084-6. Epub 2021 Jan 27.
10
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.加拿大妇产科医师学会(SOGC)和加拿大医学遗传学会(CCMG)关于生殖遗传携带者筛查的联合意见:面向直接面向消费者检测时代所有加拿大孕产妇和生殖健康护理提供者的最新信息。
J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008.

引用本文的文献

1
A dataset of estimated heterozygous individual and carrier couple frequencies for pan-ancestry carrier screening.一个用于泛族裔携带者筛查的估计杂合个体和携带者夫妇频率的数据集。
Data Brief. 2025 Jun 25;61:111835. doi: 10.1016/j.dib.2025.111835. eCollection 2025 Aug.
2
Towards a patient-centred classification of genetic disease severity.迈向以患者为中心的遗传疾病严重程度分类。
Eur J Hum Genet. 2025 Feb 18. doi: 10.1038/s41431-025-01813-0.
3
Research needs for birth defect prevention and control in China in the genomic screening era.

本文引用的文献

1
Clinical validity of expanded carrier screening: Evaluating the gene-disease relationship in more than 200 conditions.扩展携带者筛查的临床有效性:评估 200 多种疾病中的基因-疾病关系。
Hum Mutat. 2020 Aug;41(8):1365-1371. doi: 10.1002/humu.24033. Epub 2020 May 21.
2
Estimating yields of prenatal carrier screening and implications for design of expanded carrier screening panels.估算产前携带者筛查的产量及其对扩展携带者筛查面板设计的影响。
Genet Med. 2019 Sep;21(9):1940-1947. doi: 10.1038/s41436-019-0472-7. Epub 2019 Mar 8.
3
A data-driven evaluation of the size and content of expanded carrier screening panels.
基因组筛查时代中国预防出生缺陷的研究需求。
BMJ. 2024 Aug 30;386:e078637. doi: 10.1136/bmj-2023-078637.
4
Unpacking the notion of "serious" genetic conditions: towards implementation in reproductive decision-making?剖析“严重”遗传疾病的概念:如何在生殖决策中得以应用?
Eur J Hum Genet. 2025 Mar;33(2):158-166. doi: 10.1038/s41431-024-01681-0. Epub 2024 Aug 10.
5
Severity in the genomic age: the significance of lived experience to understandings of severity.基因组时代的严重性:生活经历对于理解严重性的意义。
Eur J Hum Genet. 2025 Mar;33(2):176-181. doi: 10.1038/s41431-024-01652-5. Epub 2024 Jun 26.
6
Populational pan-ethnic screening panel enabled by deep whole genome sequencing.通过深度全基因组测序实现的人群泛族裔筛查面板
NPJ Genom Med. 2023 Nov 20;8(1):38. doi: 10.1038/s41525-023-00383-8.
7
Carrier burden of over 300 diseases in Han Chinese identified by expanded carrier testing of 300 couples using assisted reproductive technology.通过对 300 对接受辅助生殖技术的夫妇进行扩展携带者检测,鉴定出汉族人群中超过 300 种疾病的携带者负担。
J Assist Reprod Genet. 2023 Sep;40(9):2157-2173. doi: 10.1007/s10815-023-02876-y. Epub 2023 Jul 14.
8
Views of healthcare professionals on the inclusion of genes associated with non-syndromic hearing loss in reproductive genetic carrier screening.医疗保健专业人员对将与非综合征性听力损失相关的基因纳入生殖遗传携带者筛查的看法。
Eur J Hum Genet. 2023 May;31(5):548-554. doi: 10.1038/s41431-022-01239-y. Epub 2023 Feb 9.
9
Attitudes of professional stakeholders towards implementation of reproductive genetic carrier screening: a systematic review.专业利益相关者对生殖遗传携带者筛查实施的态度:系统评价。
Eur J Hum Genet. 2023 Apr;31(4):395-408. doi: 10.1038/s41431-022-01274-9. Epub 2023 Jan 12.
10
Views of reproductive genetic carrier screening participants regarding screening for genes associated with non-syndromic hearing loss.具有生育遗传携带者筛查史人群对筛查非综合征型听力损失相关基因的看法。
Prenat Diagn. 2022 Dec;42(13):1658-1666. doi: 10.1002/pd.6253. Epub 2022 Nov 15.
基于数据的扩展携带者筛查面板大小和内容的评估。
Genet Med. 2019 Sep;21(9):1931-1939. doi: 10.1038/s41436-019-0466-5. Epub 2019 Feb 28.
4
Clinical utility of expanded carrier screening: results-guided actionability and outcomes.扩展携带者筛查的临床实用性:结果导向的可操作性和结果。
Genet Med. 2019 May;21(5):1041-1048. doi: 10.1038/s41436-018-0321-0. Epub 2018 Oct 11.
5
Outcome of Early Identification and Intervention on Infants with Hearing Loss Under Universal Hearing Screening Program.普遍听力筛查项目下对听力损失婴儿进行早期识别和干预的结果
J Med Assoc Thai. 2017 Feb;100(2):197-206.
6
Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results.患者对使用疾病类别进行基因组携带者筛查结果决策的看法。
Am J Med Genet A. 2018 Feb;176(2):376-385. doi: 10.1002/ajmg.a.38583. Epub 2017 Dec 18.
7
Clinical Utility of Expanded Carrier Screening: Reproductive Behaviors of At-Risk Couples.扩展携带者筛查的临床应用:高危夫妇的生殖行为
J Genet Couns. 2018 Jun;27(3):616-625. doi: 10.1007/s10897-017-0160-1. Epub 2017 Sep 27.
8
Age Limit of Pediatrics.儿科学的年龄限制。
Pediatrics. 2017 Sep;140(3). doi: 10.1542/peds.2017-2151. Epub 2017 Aug 21.
9
Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.在构建临床实用的扩展携带者筛查面板中寻求中间立场。
Obstet Gynecol. 2017 Aug;130(2):279-284. doi: 10.1097/AOG.0000000000002139.
10
Expanded carrier screening for monogenic disorders: where are we now?扩展性携带者筛查:我们现在在哪里?
Prenat Diagn. 2018 Jan;38(1):59-66. doi: 10.1002/pd.5109. Epub 2017 Jul 27.